Julie C. Lauffenburger, PharmD, PhD, is an Associate Professor in Medicine at Harvard Medical School and an Associate Epidemiologist in the Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and Women’s Hospital. Her work mainly focuses on cardiometabolic diseases where she has expertise in observational study designs, predictive analytics and pragmatic randomized trials to answer clinically-important questions related to medication use and adherence. Additional areas of research interest include developing and evaluating scalable behavioral interventions to improve healthcare delivery, especially using technology and health IT. She is currently a Principal Investigator of several projects from the National Institutes of Health and has also led work funded by the National Institute for Health Care Management (NIHCM).
Dr. Lauffenburger is also the Assistant Director of the Center for Healthcare Delivery Sciences and a practicing pharmacist at the Brigham and Women’s Hospital. At the Harvard T.H. Chan School of Public Health, she is an Assistant Professor in the Department of Epidemiology and directs the Epidemiologic Methods in Health Services Research Course (EPI235). Dr. Lauffenburger completed her PhD at the University of North Carolina at Chapel Hill and her PharmD from the University of Pittsburgh.